2024
Shaykin, Jakob D., Emily D. Denehy, Jocelyn R. Martin, Cassie M. Chandler, Dan Luo, Chase E. Taylor, Michael D. Sunshine et al. “Targeting α1-and α2-adrenergic receptors as a countermeasure for fentanyl-induced locomotor and ventilatory depression.” Environmental Toxicology and Pharmacology 110 (2024): 104527.
Anderson, Tanner L., Jack V. Keady, Judy Songrady, Navid S. Tavakoli, Artin Asadipooya, Ryson E. Neeley, Jill R. Turner, and Pavel I. Ortinski. “Distinct 5-HT receptor subtypes regulate claustrum excitability by serotonin and the psychedelic, DOI.” Progress in Neurobiology (2024): 102660.
Shaykin, Jakob, Jocelyn Martin, Cassie Chandler, Emily Denehy, Jill Turner, Warren Alilain, Thomas Prisinzano, and Michael Bardo. “ALPHA 1 AND 2 NORADRENERGIC RECEPTORS AS TARGETS FOR REVERSING FENTANYL-INDUCED RESPIRATORY DEPRESSION.” Drug and Alcohol Dependence 260 (2024): 110107.
Keady, J., & Turner, J. (2024). Developmental Impacts of Adolescent Intermittent Nicotine Vapor Exposure on the Murine Hippocampus.
Vu, L. Y., Luo, D., Johnson, K., Denehy, E. D., Songrady, J. C., Martin, J., … & Prisinzano, T. E. (2024). Searching for Synthetic Opioid Rescue Agents: Identification of a Potent Opioid Agonist with Reduced Respiratory Depression. Journal of Medicinal Chemistry, 67(11), 9173-9193.
Xia, M., Anderson, T. L., Prantzalos, E. R., Hawkinson, T. R., Clarke, H. A., Keohane, S. B., … & Ortinski, P. I. (2024). Correction: Voltage-gated potassium channels control extended access cocaine seeking: a role for nucleus accumbens astrocytes. Neuropsychopharmacology, 49(6), 1060.
Fisher, M. L., Prantzalos, E. R., O’Donovan, B., Anderson, T. L., Sahoo, P. K., Twiss, J. L., … & Turner, J. R. (2024). Dynamic effects of ventral hippocampal NRG3/ERBB4 signaling on nicotine withdrawal-induced responses. Neuropharmacology, 247, 109846.
Elder, T. R., & Turner, J. R. (2024). Nicotine use disorder and Neuregulin 3: Opportunities for precision medicine. Advances in Pharmacology (San Diego, Calif.), 99, 387-404.
Xia, M., Anderson, T. L., Prantzalos, E. R., Hawkinson, T. R., Clarke, H. A., Keohane, S. B., … & Ortinski, P. I. (2024). Voltage-gated potassium channels control extended access cocaine seeking: a role for nucleus accumbens astrocytes. Neuropsychopharmacology, 49(3), 551-560.
Kumar, M., Keady, J., Aryal, S. P., Hessing, M., Richards, C. I., & Turner, J. R. (2024). The Role of Microglia in Sex-and Region-Specific Blood-Brain Barrier Integrity During Nicotine Withdrawal. Biological Psychiatry Global Open Science, 4(1), 182-193.
2023
Turner, J. R. (2023). New Avenues for Treating Affective Dysfunction During Opioid Abstinence. Biological Psychiatry, 93(6), 482-484.
2022
Hodes, G., Kenwood, M., Der-Avakian, A., Nestler, E., Carlezon, W., Jentsch, J., … & Turner, J. (2022, December). Navigating the Maze: How You and Your University Can Prepare and Protect Your Lab Against The Risks Associated With Animal Research. In NEUROPSYCHOPHARMACOLOGY (Vol. 47, No. SUPPL 1, pp. 6-6). CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND: SPRINGERNATURE.
Keady, J., Fisher, M., Anderson, E., LeMalefant, R., & Turner, J. (2022). Age‐specific impacts of nicotine and withdrawal on hippocampal neuregulin signalling. European Journal of Neuroscience, 56(6), 4705-4719.
Ortinski, P. I., Reissner, K. J., Turner, J., Anderson, T. L., & Scimemi, A. (2022). Control of complex behavior by astrocytes and microglia. Neuroscience & Biobehavioral Reviews, 137, 104651.
Custodio, L., Malone, S., Bardo, M. T., & Turner, J. R. (2022). Nicotine and opioid co-dependence: Findings from bench research to clinical trials. Neuroscience & Biobehavioral Reviews, 134, 104507.
2021
Fisher ML, Pauly JR, Froeliger B, Turner JR.Translational Research in Nicotine Addiction.Cold Spring Harb Perspect Med. 2021 Jun 1;11(6):a039776. doi: 10.1101/cshperspect.a039776
Kumar, M., Rainville, J. R., Williams, K., Lile, J. A., Hodes, G. E., Vassoler, F. M., & Turner, J. R. (2021). Sexually dimorphic neuroimmune response to chronic opioid treatment and withdrawal. Neuropharmacology, 186, 108469.
2020
Kumar M, Adeluyi A, Anderson E, and Turner JR. Non-Neuronal Contributions to Nicotine Dependence. Neuropharmacology, In Special Issue on “Contemporary Advances in Nicotine Neuropharmacology,” Damaj, De Biasi, and Papke, Eds. (2020)
2019
O’Donovan B1, Adeluyi A2, Anderson EL2, Cole RD1, Turner JR3, Ortinski PI1. Altered gating of Kv1.4 in the nucleus accumbens suppresses motivation for reward. eLIFE. 2019 Sep 5;8. pii: e47870. doi: 10.7554/eLife.47870.
Adeluyi A, Guerin L, Fisher ML, Galloway A, Cole RD, Chan SSL, Wyatt MD, Davis SW, Freeman L, Ortinski PI, Turner JR*. Microglia Morphology and Pro-Inflammatory Signaling in the Nucleus Accumbens during Nicotine Withdrawal. Science Advances. 09 Oct 2019: Vol. 5,no. 10, eaax7031, DOI: 10.1126/sciadv.aax7031.
Book Chapters
Fowler C, Turner JR, and Damaj I (2019). Molecular Mechanisms Associated with Nicotine Pharmacology and Dependence. In: Substance Use Disorders: From Etiology to Treatment (Nader M and Hurd Y, Eds.).
Fisher ML, Pauley J, Froeliger B, Turner JR (2019). Translation Research in Nicotine Addiction. In Addiction, 2nd Edition (Pierce RC and Kenney P, Eds.) Cold Spring Harbor Laboratory Press.
2017
Zhou L, Fisher ML, Cole RD, Gould TJ, Parikh V, Ortinski PI, Turner JR. Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition. Neuropsychopharmacology. 2018 May;43(6):1343-1354. doi. 10.1038/npp.2017.278.
Hines TJ, Gao X, Sahu S, Lange M, Turner JR, Twiss JL, Smith DS. An Essential Post-Developmental Role for Lis1 in Mice. eNeuro. 2018 Feb 2;5(1). pii: ENEURO.0350-17.2018. doi: 10.1523/ENEURO.0350-17.2018.
Ashley Galloway1,2, Adewale Adeluyi3, Bernadette O’Donovan1, Miranda Fisher3, Chintada Nageswara Rao3, Peyton Critchfield1, Mathew Sajish3, Jill R Turner3, Pavel I. Ortinski.1 Astrocytes respond to dopamine by stimulation of PARP1-mediated NAD+ metabolism. J Neurosci. 2018 May 23;38(21):4846-4858. doi: 10.1523/JNEUROSCI.3349-17.2018. Epub 2018 Apr 30.
Fisher ML, LeMalefant R, Zhou L, Huang G, Turner JR (2016). Distinct Roles of CREB within the Ventral and Dorsal Hippocampus in Mediating Nicotine Withdrawal Phenotypes. Neuropsychopharmacology. 2017 Jul;42(8):1599-1609. doi: 10.1038/npp.2016.257.
Vassoler F, Oliver DJ, Wyse C, Blau A, Shtutman M, Turner JR, Byrnes EM. Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure. Neuropharmacology. 2017 Feb;113(Pt A):271-280. doi: 10.1016/j.neuropharm.2016.10.006.
Zhou L, Fisher ML, Cole RD, Gould TJ, Parikh V, Ortinski PI, Turner JR. Neuregulin 3 Signaling Mediates Nicotine-Dependent Synaptic Plasticity in the Orbitofrontal Cortex and Cognition. Neuropsychopharmacology. 2017 Nov 7. doi: 10.1038/npp.2017.278. [Epub ahead of print]
2016
Zhou L, Andersen H, Arreola A, Turner JR, Ortinski P. Behavioral history of withdrawal influences regulation of cocaine seeking by glutamate re-uptake.PLOSone. In Press.
Vassoler F, Oliver DJ, Wyse C, Blau A, Shtutman M, Turner JR, Byrnes EM. Transgenerational attenuation of opioid self-administration as a consequence of adolescent morphine exposure. Neuropharmacology. In Press.
Fisher ML, LeMalefant R, Zhou L, Huang G, Turner JR (2016). Distinct Roles of CREB within the Ventral and Dorsal Hippocampus in Mediating Nicotine Withdrawal Phenotypes.Neuropsychopharmacology. Nov 16. doi: 10.1038/npp.2016.257. [Epub ahead of print]
2015
Mague SM, Port RG, McMullen ME, Carlson GC, and Turner JR (2015). Mouse Model of OPRM1 (A118G) Polymorphism has Altered Hippocampal Function. Neuropharmacology. In Press.
Fisher ML, Loukola A, Kaprio J, and Turner JR (2015). Role of the Neuregulin Signaling Pathway in Nicotine Dependence and Co-Morbid Disorders. In: Nicotine Dependence and Mental Illness (De Biasi M, Ed.). Elsevier Press.
Forcelli P, Turner JR, Lee BG, Olson T, Xie T, Xiao Y, Blendy JA, Kellar KJ (2015). Anxiolytic- and Antidepressant-like Effects of the Methadone Metabolite 2-ethyl-5-methyl-3,3-diphenyl-1-pyrroline (EMDP).Neuropharmacology. In Press.
Gomez AM, Altomare D, Sun WL, Midde NM, Ji H, Shtutman M, Turner JR, Creek KE, Zhu J. Prefrontal microRNA-221 Mediates Environmental Enrichment-Induced Increase of Locomotor Sensitivity to Nicotine. Int J Neuropsychopharmacol. 2015 Aug 1. pii: pyv090. doi: 10.1093/ijnp/pyv090. [Epub ahead of print
2014
Hussmann G*, DeDominicis K*, Turner JR*, Yasuda RP, Klehm J, Xiao Y, Richardson J, Sahibzada N, Wolfe BB, Lindstrom J, Blendy JA, and Kellar KJ (2014). Chronic Sazetidine-A Administration Following Chronic Nicotine Allows Increased Densities of Neuronal Nicotinic Receptors to Return to Control Levels in Rodent Brain. J Neurochem. May;129(4):721-31. doi: 10.1111/jnc.12653.
Yohn N, Turner JR, Blendy JA (2014). Activation of α4β2*/α6β2* Nicotinic Receptors Alleviates Anxiety During Nicotine Withdrawal Without Upregulating Nicotinic Receptors.JPET. May;349(2):348-54. doi: 10.1124/jpet.113.211706.
Turner JR, Ray R, Lee B, Jepson C, Kaestner K, Lerman C, and Blendy JA (2014) Evidence from Mouse and Man for a Role of Neuregulin 3 in Nicotine Dependence.Molecular Psychiatry. 014 Jul;19(7):801-10. doi: 10.1038/mp.2013.104.
2013
Wilkinson D, Turner JR, Blendy JA, and Gould T (2013) Genetic Underpinnings of Nicotine-withdrawal Behaviors: Fear Conditioning Withdrawal Deficits are Dependent upon Upregulation of nAChRs in the Dorsal, but not the Ventral, Hippocampus.Psychopharmacology225(1):201-8.
*Hussman P, *Turner JR, Levin ED, Blendy JA, Kellar KJ (2013). Chronic Sazetidine-A at Behaviorally Active Doses Does Not Increase Nicotinic Cholinergic Receptors in Rodent Brain.JPET343:441-50.
Turner JR, Ecke L, Briand L, Haydon PG, and Blendy JA (2013) Cocaine-related Behaviors in Mice with Deficient Gliotransmission.Psychopharmacology226:167-76.
Turner JR, Wilkinson D, Poole R, Gould T, Carlson GC, Blendy J (2013). Divergent Functional Effects of Sazetidine-A and Varenicline during Nicotine Withdrawal.Neuropsychopharmacology38:2035-47.
Ortinski P, Turner JR, Pierce RC (2013) Extrasynaptic targeting of NMDA receptors following D1 dopamine receptor activation and cocaine self-administration.J Neurosci33: 9451-61.
Turner JR, Gold A, Schnoll R, and Blendy JA (2013). Translational Research in Nicotine Addiction. In: Addiction (Pierce RC and Kenney P, eds). CSH: Cold Spring Harbor Laboratory Press.
2012
Portugal G, Wilkinson D, Turner JR, Blendy JA, and Gould T (2012) Developmental Effects of Acute, Chronic, and Withdrawal from Chronic Nicotine on Fear Conditioning.Neurobiology of Learning and Memory 97:482-94.
Hilario M, Turner JR, Blendy J (2012). Reward sensitization: effects of repeated nicotine exposure and withdrawal in mice. Neuropsychopharmacology37: 2661-70.
Balu DT, Turner JR, Brookshire BR, Hill-Smith TE, Blendy JA, and Lucki I (2012) Brain Monoamines and Antidepressant-like Responses in MRL/MpJ Versus C57BL/6J Mice.Neuropharmacology67C: 503-510.
2011
Turner JR, Castellano LM, and Blendy JA (2011) Parallel upregulation of neuronal nicotinic receptors and anxiolytic effects following chronic nicotine and varenicline.Nicotine and Tobacco Research.13:41-6.
Turner JR, Ortinski PI, Sherrard R, and Kellar KJ (2011). Nicotinic Cholinergic Receptors are Located on Distinct Cell Populations in the Rat Cerebellum: Implications for Diverse Functional Roles.Cerebellum. 10:748-57.
2010 & before
Turner JR and Kellar KJ (2005) Nicotinic cholinergic receptors in the rat cerebellum: multiple heteromeric subtypes.J. Neurosci. 25:9258-9265.
Ortinski PI, Turner JR, Barberis A, Motamedi G, Yasuda, RP, Wolfe BB, Kellar KJ and Vicini S (2006) Deletion of the GABAA receptor α1 subunit increases tonic GABAA receptor current: A role for GABA uptake transporters. J. Neurosci. 26:9323-9331.
Turner JR, Castellano LM, and Blendy JA (2010) Nicotinic partial agonists varenicline and sazetidine-A have differential effects on affective behavior. JPET, 334:665-72.
